×

Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

  • US 7,655,688 B2
  • Filed: 12/19/2005
  • Issued: 02/02/2010
  • Est. Priority Date: 02/27/2001
  • Status: Active Grant
First Claim
Patent Images

1. A method of modulating the function of a nuclear hormone receptor in a mammal for the treatment of cancer, wherein the cancer cells express estrogen receptor, or contain progesterone or androgen receptor, comprising administering to the mammal an effective nuclear receptor modulating amount of a compound of the following formula (I) or a pharmaceutical acceptable salt thereof:

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×